Literature DB >> 8169912

Characterization of antiphospholipid antibodies in women with recurrent spontaneous abortions.

W Matzner1, P Chong, G Xu, W Ching.   

Abstract

Antiphospholipid antibodies are important in the etiology of recurrent pregnancy loss. To date, most studies have concentrated on antibodies to cardiolipin specifically. In this study, the serum of 352 women with recurrent pregnancy loss was studied by enzyme-linked immunosorbent assay for antibodies to six phospholipid epitopes: cardiolipin, phosphoserine, phosphoglycerol, phosphoethanolamine, phosphatidic acid and phosphoinositol. Of these women, 59.1% had either an IgG or IgM antibody to one of the six phospholipids. This compared to only 4.6% in the control group. Approximately 75% of the isotypes were IgM. The most common phospholipid epitope was phosphoserine. However, in patients with antibodies to only one phospholipid, phosphoethanolamine was the most common. These findings support recent evidence that antiphospholipid antibodies may interfere with the formation of syncytiotrophoblasts in the placenta. In addition, antiphospholipid antibodies occur more frequently in patients who suffer recurrent miscarriages than was previously thought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169912

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

Review 1.  Low molecular weight heparin in immunological recurrent abortion--the incredible cure.

Authors:  Gautam N Allahbadia; Swati G Allahbadia
Journal:  J Assist Reprod Genet       Date:  2003-02       Impact factor: 3.412

2.  Antiphospholipid antibodies associated with implantation failure after IVF/ET.

Authors:  C B Coulam; B D Kaider; A S Kaider; P Janowicz; R G Roussev
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

3.  The incidence of various antiphospholipid antibodies, measured by commercial-based laboratory, with recurrent spontenous abortion and the impact of their profiles on reproductive outcome with active anticoagulant therapy.

Authors:  Nagayoshi Umehara; Tadao Tanaka
Journal:  ISRN Obstet Gynecol       Date:  2012-03-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.